About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(MAPT)8cPdav
transgene insertion 8c, Peter Davies
MGI:3057129
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Mapttm1(EGFP)Klt/Mapttm1(EGFP)Klt
Tg(MAPT)8cPdav/0
B6.Cg-Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J MGI:5008417
cx2
Apptm1Ck/Apptm1Ck
Psen1tm1Mpm/Psen1tm1Mpm
Tg(MAPT)8cPdav/0
B6.Cg-Psen1tm1Mpm Apptm1Ck Tg(MAPT)8cPdav MGI:5581681
cx3
Mapttm1(EGFP)Klt/Mapttm1(EGFP)Klt
Tg(MAPT)8cPdav/?
involves: 129S4/SvJae * C57BL/6 * Swiss Webster MGI:3663749


Genotype
MGI:5008417
cx1
Allelic
Composition
Mapttm1(EGFP)Klt/Mapttm1(EGFP)Klt
Tg(MAPT)8cPdav/0
Genetic
Background
B6.Cg-Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapttm1(EGFP)Klt mutation (3 available); any Mapt mutation (393 available)
Tg(MAPT)8cPdav mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• 6 month old mutants exhibit slower visuospatial learning than control mice (J:172426)
• in the visuospatial re-learning test performed at 7, 8, 9, and 15 months of age, mutants exhibit a decrease in the speed of re-learning the task compared to controls (J:172426)
• however, mutants perform better than Tg(APPswe,PSEN1dE9)85Dbo mice on the visuospatial re-learning test at 9 and 18 months of age (J:172426)
• 6 month old mutants exhibit slower visuospatial learning than control mice (J:172426)
• in the visuospatial re-learning test performed at 7, 8, 9, and 15 months of age, mutants exhibit a decrease in the speed of re-learning the task compared to controls (J:172426)
• however, mutants perform better than Tg(APPswe,PSEN1dE9)85Dbo mice on the visuospatial re-learning test at 9 and 18 months of age (J:172426)

taste/olfaction
N
• mutants do not exhibit Alzheimer's disease-related impairment in olfactory performance in tests based on an operant conditioning procedure and in tests based on a habituation/dishabituation procedure (J:172426)
• mutants do not exhibit Alzheimer's disease-related impairment in olfactory performance in tests based on an operant conditioning procedure and in tests based on a habituation/dishabituation procedure (J:172426)

nervous system

Mouse Models of Human Disease
OMIM ID Ref(s)
Alzheimer Disease; AD 104300 J:172426




Genotype
MGI:5581681
cx2
Allelic
Composition
Apptm1Ck/Apptm1Ck
Psen1tm1Mpm/Psen1tm1Mpm
Tg(MAPT)8cPdav/0
Genetic
Background
B6.Cg-Psen1tm1Mpm Apptm1Ck Tg(MAPT)8cPdav
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Apptm1Ck mutation (0 available); any App mutation (10 available)
Psen1tm1Mpm mutation (2 available); any Psen1 mutation (22 available)
Tg(MAPT)8cPdav mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• in the elevated plus maze, 4 month old mice spend less time on the open arm, indicating increased anxiety (J:209782)
• however, mice show normal nociception in the hot plate assay (J:209782)
• in the elevated plus maze, 4 month old mice spend less time on the open arm, indicating increased anxiety (J:209782)
• however, mice show normal nociception in the hot plate assay (J:209782)
• mice show slightly higher pre-shock freezing frequency and increased contextual freezing frequency at 4 and 12 months of age, indicating exaggerated fear response (J:209782)
• mice show slightly higher pre-shock freezing frequency and increased contextual freezing frequency at 4 and 12 months of age, indicating exaggerated fear response (J:209782)
• mice show increased contextual freezing frequency at 4 and 12 months of age (J:209782)
• however, cued freezing frequency is unaffected and mice do not exhibit spatial memory deficits in the Morris water maze (J:209782)
• mice show increased contextual freezing frequency at 4 and 12 months of age (J:209782)
• however, cued freezing frequency is unaffected and mice do not exhibit spatial memory deficits in the Morris water maze (J:209782)
• in the open field, the total travel distance is reduced at 12, but not 4, months of age, indicating age-dependent reduced activity (J:209782)
• in the open field, the total travel distance is reduced at 12, but not 4, months of age, indicating age-dependent reduced activity (J:209782)

homeostasis/metabolism
• mice exhibit amyloid beta plaques on the outer edge of the cortex at 18-22 months of age which progress into inner layers of the cortex and hippocampus by 26-29 months of age (J:209782)
• mice exhibit amyloid beta plaques on the outer edge of the cortex at 18-22 months of age which progress into inner layers of the cortex and hippocampus by 26-29 months of age (J:209782)

nervous system
• mice exhibit amyloid beta plaques on the outer edge of the cortex at 18-22 months of age which progress into inner layers of the cortex and hippocampus by 26-29 months of age (J:209782)
• mice exhibit amyloid beta plaques on the outer edge of the cortex at 18-22 months of age which progress into inner layers of the cortex and hippocampus by 26-29 months of age (J:209782)
• increase in phosphorylated tau in the cortex and hippocampus (J:209782)
• increase in phosphorylated tau in the cortex and hippocampus (J:209782)

Mouse Models of Human Disease
OMIM ID Ref(s)
Alzheimer Disease; AD 104300 J:209782




Genotype
MGI:3663749
cx3
Allelic
Composition
Mapttm1(EGFP)Klt/Mapttm1(EGFP)Klt
Tg(MAPT)8cPdav/?
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * Swiss Webster
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mapttm1(EGFP)Klt mutation (3 available); any Mapt mutation (393 available)
Tg(MAPT)8cPdav mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• phosphorylated tau accumulates in neuronal cell bodies and dendrites of the hippocampus and neocortex as early as 3 months of age (J:84638)
• in particular, accumulations occur in entorhinal cortex, ventromedial hypothalamus, medial septum and the nucleus of the horizontal limb of the diagonal band (J:84638)
• increase in tau phosphorylation occurs at serine 202, threonine 231 and serine 235 as determined by immunoblot (J:84638)
• tau aggregates in the proximal dendrites have an average width of 15 nm and are not densely packed (J:84638)
• insoluble tau is present in both 2 and 9 month old mice (J:84638)
• paired helical filaments are observed in 9, 12 and 14 month old mice (J:84638)
• paired helical filaments are observed in 9, 12 and 14 month old mice (J:84638)
• phosphorylated tau accumulates in neuronal cell bodies and dendrites of the hippocampus and neocortex as early as 3 months of age (J:84638)
• in particular, accumulations occur in entorhinal cortex, ventromedial hypothalamus, medial septum and the nucleus of the horizontal limb of the diagonal band (J:84638)
• increase in tau phosphorylation occurs at serine 202, threonine 231 and serine 235 as determined by immunoblot (J:84638)
• tau aggregates in the proximal dendrites have an average width of 15 nm and are not densely packed (J:84638)
• insoluble tau is present in both 2 and 9 month old mice (J:84638)
• cells in the cortex and hippocampus appear irregularly shaped, often with distorted processes in 13 month old mice (J:84638)
• cells in the cortex and hippocampus appear irregularly shaped, often with distorted processes in 13 month old mice (J:84638)

hematopoietic system
• splenic red pulp is largely obliterated (J:174270)
• splenic red pulp is largely obliterated (J:174270)
• splenic white pulp contains follicles that are larger and more irregular in shape than normal follicles and are often fused with adjacent follicles (J:174270)
• splenic white pulp contains follicles that are larger and more irregular in shape than normal follicles and are often fused with adjacent follicles (J:174270)

immune system
• splenic red pulp is largely obliterated (J:174270)
• splenic red pulp is largely obliterated (J:174270)
• splenic white pulp contains follicles that are larger and more irregular in shape than normal follicles and are often fused with adjacent follicles (J:174270)
• splenic white pulp contains follicles that are larger and more irregular in shape than normal follicles and are often fused with adjacent follicles (J:174270)

renal/urinary system
• kidney glomeruli are dilated probably due to obstruction from the amyloid in the lumen or walls of medullary tubules especially in the papilla (J:174270)
• kidney glomeruli are dilated probably due to obstruction from the amyloid in the lumen or walls of medullary tubules especially in the papilla (J:174270)

tumorigenesis
• malignant lymphoma in the spleen and lymph nodes are seen in some mutants (J:174270)
• megakaryocytes are numerous is some spleens, suggesting a relation to megakaryocytic leukemia (J:174270)
• malignant lymphoma in the spleen and lymph nodes are seen in some mutants (J:174270)
• megakaryocytes are numerous is some spleens, suggesting a relation to megakaryocytic leukemia (J:174270)
• splenic architecture is replaced by proliferated immature mononuclear cells arranged in follicular aggregates indicating follicular lymphoma (J:174270)
• splenic architecture is replaced by proliferated immature mononuclear cells arranged in follicular aggregates indicating follicular lymphoma (J:174270)

homeostasis/metabolism
• some mutants older than 18 months exhibit amyloid deposits in the spleen, kidneys, liver, ovary and/or heart (J:174270)
• amyloid is deposited concentrically in the perifollicular sheath, partly or completely encircling the follicles in the spleen (J:174270)
• in the liver, amyloid deposit is in the walls of sinusoids or central veins (J:174270)
• in the kidney, amyloid deposits are seen in the glomeruli (J:174270)
• amyloid deposits in the heart are not composed of amyloid-beta peptide, but rather amyloid A (J:174270)
• some mutants older than 18 months exhibit amyloid deposits in the spleen, kidneys, liver, ovary and/or heart (J:174270)
• amyloid is deposited concentrically in the perifollicular sheath, partly or completely encircling the follicles in the spleen (J:174270)
• in the liver, amyloid deposit is in the walls of sinusoids or central veins (J:174270)
• in the kidney, amyloid deposits are seen in the glomeruli (J:174270)
• amyloid deposits in the heart are not composed of amyloid-beta peptide, but rather amyloid A (J:174270)

Mouse Models of Human Disease
OMIM ID Ref(s)
Alzheimer Disease; AD 104300 J:84638 , J:174270





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory